Guenther Koehne
Baptist Health Herbert Wertheim Cancer Insitute · Baptist Health Herbert Wertheim Cancer Institute · Miami Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Guenther Koehne as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:04 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05617625 · CD34+ Enriched Transplants to Treat Myelodysplastic SyndromeGuenther Koehne · not yet recruiting · Myelodysplastic Syndromes, Graft Vs Host Disease, Graft-versus-host-disease · principal investigator
- Ph2NCT05565105 · CD34+ Transplants for Myeloid MalignanciesGuenther Koehne · not yet recruiting · Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute · principal investigator
- Ph1NCT05350163 · T-cell Receptor α/β Depleted Donor Lymphocyte InfusionGuenther Koehne · terminated · Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor · principal investigator
- Ph1/Ph2NCT04982354 · Induction Therapy for Patients With FLT3 Mutated Acute Myeloid LeukemiaGuenther Koehne · withdrawn · Acute Myeloid Leukemia · principal investigator
- Ph2NCT04684979 · Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid MalignanciesBaptist Health South Florida · withdrawn · B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma · principal investigator
- Ph2NCT04282174 · CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesBaptist Health South Florida · withdrawn · Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT01827137 · WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell TransplantationSellas Life Sciences Group · completed · Multiple Myeloma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:04 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.Nat Med · 2023617 citationsRCR 54.5
- Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.Sci Transl Med · 2018309 citationsRCR 11.1
- Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.J Clin Invest · 2020203 citationsRCR 9.8
- 164 citationsRCR 3.8
- Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.Biol Blood Marrow Transplant · 201584 citationsRCR 2.8
- 72 citationsRCR 2.0
- T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.Biol Blood Marrow Transplant · 201168 citationsRCR 1.9
- Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.Bone Marrow Transplant · 199646 citationsRCR 1.5
- High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Biol Blood Marrow Transplant · 201541 citationsRCR 1.4
- Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.Biol Blood Marrow Transplant · 201741 citationsRCR 1.4